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Vascular thrombosis in the neonatal period is a relatively rare
entity. However, its incidence has increased in recent years due to
the higher sensitivity of imaging techniques. The thrombosis can
occur in different locations, being cerebral venous sinus thrombosis
(CVST) the most common [1].
There are several congenital or acquired factors that may favor
the development of thrombosis in the newborn, including infec-
tion, dehydration, birth trauma, congenital heart disease, and
presence of central catheters. Maternal factors such as pre-
eclampsia, diabetes or drug use may play a role as well [1e3]. An
inherited thrombophilia, as a single cause or combined with other
factors, may underlay.
The meta-analysis by Kenet et Lütkhoff presents the risk, esti-
mated by odds ratio (ORs), for major genetic prothrombotic factors
in children after a ﬁrst episode of stroke (3,2e11,86), been OR for
elevated Lp(a) in neonate's blood 6,27 (95% conﬁdence interval
4.52e8.69) [4].
Current protocols for the study of prothrombotic factors applied
to newborns may include determination in maternal and neonatal
blood of Lp(a). This is a lipoprotein with a lipid composition similar
to low-density lipoprotein which differs from structure, consisting
in two major proteins, apolipoprotein B and apolipoprotein (a).* Corresponding author. Alvaro Cunqueiro University Hospital, Clara Campoamor,
Spain.
E-mail addresses: egcolmenero@yahoo.es (E. Gonzalez-Colmenero), msuarezalbo@
yahoo.es (M. Suarez-Albo), acongui@gmail.com (A. Concheiro-Guisan).
Peer review under responsibility of Pediatric Hematology Oncology Chapter of
Indian Academy of Pediatrics.
http://dx.doi.org/10.1016/j.phoj.2016.08.001
2468-1245/© 2016 Pediatric Hematology Oncology Chapter of Indian Academy of Pediatr
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).In vitro studies demonstrated that Lp(a) competes with plasmin-
ogen for the receptor binding sites of endothelial cells and may
interferewith ﬁbrinolysis in endothelium and predispose thrombus
formation. Although the mechanism whereby elevated maternal
Lp(a) may favor thrombosis in the neonate is not well established, it
may be related to the activation of the coagulation cascade in the
feto-placental unit [5].
The aim of this article is to highlight the importance of maternal
and neonatal elevated Lp(a) as a risk factor for vascular thrombosis
in neonates.2. Observations
We present three neonatal cases diagnosed with venous
thrombosis where a signiﬁcant increase in Lp (a) in mother and/or
newborn's serum was detected.3. Case 1
A 8-day-old male neonate presented at the emergency room
with focal clonic seizures of right hemisphere. Familiar history of
thromboembolism, hyperhomocysteinemia and hypercholester-
olemia in several members of paternal branchwas reported. Hewas
born after instrumental delivery (forceps) and no other perinatal
landmarks were recorded. The EEG tracing showed paroxysmal
activity in the left cerebral hemisphere. A metabolic or infectious
origin of the crises, easily controlled with anticonvulsants, was
discarded. Transfontanellar ultrasound showed a small hemor-
rhagic focus at left thalamus. CVST in the doppler study was sus-
pected. Magnetic resonance (MR) of the brain conﬁrmed massive
venous sinus thrombosis (superior sagittal, straight and proximal
segment of both transverse sinuses). Other MR ﬁndings were in-
ternal cerebral veins thrombosis with small foci compatible with
subacute hemorrhagic infarcts (Fig. 1). Doppler ultrasound study
ruled out thrombosis at large cervical vessels and extracranial lo-
cations. The study of thrombophilic factors in the newborn and
their parents was normal (included homocysteine and MTHFR
determinations), except elevated Lp(a) in the mother (52 mg/dL).
After diagnosis, treatment with subcutaneous enoxaparin (1.5 mg/
kg every 12 h) was initiated and held for four months. Treatment
was well tolerated with no alterations in platelet count neither
increasing of the intracranial hemorrhagic foci on serial ultrasoundics. Production and hosting by Elsevier B.V. This is an open access article under the
Fig. 1. Case 1: A 8 day-old male newborn with focal epileptic seizures and thalamic
hemorrhage in cerebral ultrasound, doppler suggestive of cerebral venous thrombosis
(CVST). Brain MR (sagittal and axial sections): high signal on T1-weighted MR is seen in
thalamus and in the superior sagittal, straight and proximal segment of both trans-
verse sinuses. “Empty delta sign” is formed by the image of ﬁlling defect of the pos-
terior portion of the sagittal sinus after contrast administration.
Fig. 2. Case 2. Left renal vein thrombosis after reperfusion with enoxaparin. Tc 99m-
DMSA renal scintigraphy shows differential uptake in both kidneys (56% and 44% for
right and left kidney respectively) considered almost normal function.
Fig. 3. Case 3. Neonatal meningitis and cerebral CVST. Cerebral MR (axial section):
Increased signal on T1 level of the superior sagittal sinus sugestive of thrombosis and
large areas of hemorraghic infarction at left temporal and parietal lobes. Subgaleal
bleeding (cephalohematoma) and ventricular dilatation.
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patency of the venous sinuses in the absence of other injuries.
Prothrombotic study was repeated again at 2 months of age,
showing no anomalies. At 4 years follow up, the patient had a
normal neurodevelopmental for age, without developing second-
ary epilepsy neither having presented new thrombotic phenomena.
Mother's Lp(a) levels remained high despite dietetic measures.
4. Case 2
A 3 days-old female neonate was referred to our center after
gross hematuria and palpation of a left abdominal mass. No
remarkable ﬁndings in the obstetric records were found. She was
born at term by instrumental delivery (vacuum). Abdominal ul-
trasound showed an enlarged left kidney with alterations in their
echostructure and a left adrenal hemorrhage, both suggestive of
renal vein thrombosis. Doppler study was inconclusive for throm-
bosis so abdominal MR was performed and a hyperintense image
was identiﬁed in T1 compatible with thrombus in left renal vein.
Thrombosis at the vena cava was discarded. The patient had no
oliguria or arterial hypertension and maintained biochemical pa-
rameters of renal function in normal range. Thrombophilic factors
study demonstrated a high Lp(a) in the mother (113 mg/dL) with
normal values in the newborn. Cerebral thrombosis was ruled out
by echo Doppler, and treatment was initiated with subcutaneous
enoxaparin and maintained for 3 months. Serial ultrasound scans
showed resolution of thrombosis in less than two weeks. Renal
isotopic study one month after the episode (Fig. 2) showed a
minimally asymmetrical uptake for both kidneys (56% for right
kidney and 44% for left kidney). At 3 years follow-up the patient
was asymptomatic and maintained bilateral normal renal function.
Maternal lipoprotein levels descended to close to normal levels.
5. Case 3
16-days-old male neonate was admitted to Intensive Care Unit
after generalized tonic seizure and lethargic state. One of his uncleshad suffered from stroke at 8 years of age. Reviewing obstetric
history, we did not ﬁnd anything uncommon except an instru-
mented birth (vacuum). Patient was apyretic but hypotonic and
hyporesponsive, and he showed a bulging anterior fontanelle. Brain
ultrasound showed severe ventricular hydrocephalus. A ventricular
drainage was urgently placed obtaining purulent cerebrospinal
ﬂuid (culture was positive for Escherichia coli). Antibiotic treatment
was immediately started. Brain MR was performed and showed
generalized CVST (affecting superior sagittal, straight, transverse
and sigmoid sinuses), associated with extensive areas of hemor-
rhagic infarction at temporal and parietal left lobes (Fig. 3). Treat-
ment was initiated with subcutaneous enoxaparin and maintained
for 3months. Hereditary thrombophilia study found elevated levels
of Lp(a) in both the mother (195 mg/dl) and the patient (72 mg/dl).
Serial ultrasound scans and MR after 24 days of anticoagulation
treatment demonstrated resolution of sinus thrombosis. The pa-
tient had an unfavorable neurologic outcome with the develop-
ment of epilepsy and cerebral palsy.6. Discussion
Underlying medical conditions of hereditary origin, favor
thrombosis in the neonate in isolation or in the presence of other
risk factors [15].
One of this prothrombotic factors may be the elevation in
newborn's blood of Lp(a) [6e8]. In the study conducted by Heller
Table 1
Diagnostic Protocol for neonatal thrombosis at University Hospital of Vigo.
Study of basic and enhanced coagulation
Antithrombin levels
Anticardiolipin antibodies (IgG and IgM)
Beta 2 glycoprotein antibodies (IgG and IgM)
Lupus anticoagulant antibody
Lipoprotein (a)
Homocysteine and MTHFR gen determination
Protein C, Protein S
Factor II G20210A mutation
Factor V Leiden mutation G1691A
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important independent prothrombotic risk factor in pediatric pa-
tients with CVST. A high maternal Lp(a) proﬁle as a prothrombotic
factor has been published in some cases of neonatal thrombosis,
particularly renal vein thrombosis, as it was in one of our cases 8,9.
The incidence of diagnosed vascular thrombosis in our unit is 2
cases/10.000 live births. We conduct an extensive diagnostic pro-
tocol to rule out any subjacent procoagulant disorder (Table 1). The
study is repeated after the neonatal period. In the three cases that
we have presented, Lp(a) was the only isolated factor found. This
fact does not imply that it was the sole cause of thrombosis, as other
circumstances such as infection of the central nervous system or
obstetric trauma, may be involved. Probably, the elevated Lp(a) acts
as a contributing factor in a similar way as hyperhomocysteinemia
does.
According to a study by Ulrike Nowak-Gottl et al. [5], most pa-
tients with thrombosis and Lp(a) high determinations had positive
family history such as myocardial infarction in young age, stroke or
venous thrombosis. This highlights the importance of expanding
the study of prothrombotic factors in child and family.
Determination of prothrombotic factors in the child and his
family may be important to determine the risk of thrombosis
recurrence, as well as to establish prophylactic anticoagulant
therapy if prolonged immobilization or surgery. Other preventive
measures such as dietary control have proved ineffective in con-
trolling elevated levels of Lp(a) [3].
In relation to elevated Lp(a) in the mother, it has to be clariﬁed
that this elevation may be physiological in pregnancy and puer-
perium. Maternal Lp(a) levels may be interpreted with caution, the
widely accept cutoff of 30 mg/mL could probably be not valuable in
the peripartum period, and be monitored beyond puerperium [10].
We should mention that only in one mother-case elevated Lp (a)
levels diminished to normal values after puerperium, nevertheless
during puerperium they were three times over the normal range.
More physiopatological studies to establish its role in neonatal
thrombosis should be performed.
For diagnosis, given the low speciﬁcity of symptoms (convul-
sions, altered consciousness level …) is particularly important the
early employment of Doppler ultrasound. MR is useful in the case of
cerebral thrombosis and assesses the degree of extension of
vascular infarction [2].
We observed the safety and efﬁcacy of subcutaneous enoxaparin
for the treatment in our patients with thrombosis resolved after one
month and functional recovery in two cases. The use of enoxaparinin newborns and children is well documented and included as a
recommendation in the guidelines on antithrombotic therapy of the
American College of Chest Physicians (2012). Although functional
cancellation of the kidney occurs in up to 70% of cases [9] if it is not
resolved early and completely, our patient achieved normal function
of both kidneys.References
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